BioSpace News Archive

Deals

Correction of Press Release on Invitation to Annual General Meeting in RaySearch Laboratories AB (publ)

The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Tuesday, May 21, 2019, at 6:00 p.m., at the company’s offices at Sveavägen 44, 7th floor, Stockholm, Sweden.

April 16, 2019
·
10 min read
Business

Partnership For Safe Medicines Launches Advertising Campaign In Florida To Oppose Importation

Importation undermines our core efforts to keep our medicine supply safe.

April 16, 2019
·
3 min read
Business

Johnson & Johnson Reports 2019 First-Quarter Results:

Johnson & Johnson announced results for first-quarter 2019.

April 16, 2019
·
21 min read
Deals

Canopy Growth Expands European Footprint, Acquires Spanish Licensed Cannabis Producer Cafina

Canopy Growth Corporation is pleased to announce that it has completed an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales, S.L..

April 16, 2019
·
6 min read
Drug Development

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

Aims to augment current cancer therapies by altering patients’ gut microbiome to improve response

April 16, 2019
·
5 min read
Business

SpeeDx and Cepheid Announce Test Partnership

SpeeDx tests will be available through Cepheid’s FleXible Cartridge programme for the GeneXpert System

April 16, 2019
·
5 min read
FDA

Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)

Aprea Therapeutics announced that the U.S. Food and Drug Administration has granted Fast Track designation to APR-246 for the treatment of patients with MDS having a TP53 mutation.

April 16, 2019
·
4 min read
Deals

Annual General Meeting in Oncopeptides AB (publ) on 21 May 2019

The shareholders in Oncopeptides AB are hereby given notice to attend the Annual General Meeting to be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden, Tuesday 21 May 2019 at 2.00 p.m.

April 16, 2019
·
37 min read
Policy

RepliCel Secures Several New Patents for its Regenerative Medicine Technologies

Tendon Regeneration, Skin Rejuvenation and Dermal Injector Patents Granted in the United States, Europe, South Africa, Hong Kong, China, and Japan

April 16, 2019
·
3 min read
Business

Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors

Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular conditions, announced the appointment of Paul Edick as Chairman of its Board of Directors.

April 16, 2019
·
2 min read